In one paragraphArticle in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Amy L ForehandDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-1420-1415 Kinga MalezynaDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Keena S ThomasDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
Ian J GlomskiDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0009-0006-3738-3430 Cynthia Nau CornelissenInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.ORCID 0000-0001-6294-6588 Ahmad JomaaDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-5543-7942 Alison K CrissDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0001-7738-3757 Funding
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3MNeisseria gonorrhoeae metal transporters that subvert nutritional immunityR01AI127793 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CYNTHIA N CORNELISSEN, Alison K Criss · 2017 to 2026
$6.8MUnraveling the Mechanisms of Protein Sorting and Localization to OrganellesR35GM160490 · NIGMS · UNIVERSITY OF VIRGINIA · PI Ahmad Jomaa · 2025 to 2026
$888kNational Science Foundation 2503218NIAID NIH HHS R01 AI127793NIAID NIH HHS T32 AI007046NIGMS NIH HHS R35 GM160490the Searle Scholars Program SSP-2023-106
6 · The paper itselfAbstract
To enhance its pathogenic potential, IMPORTANCE: Zinc acquisition is crucial for growth and infectivity of
Indexed as
Bacterial ProteinsNeisseria gonorrhoeaeProtein BiosynthesisRibosomal ProteinsZincGene Expression Regulation, BacterialOperonBacterial ProteinsRibosomal ProteinsZincNeisseria gonorrhoeaenutritional immunityribosometranslationzinc
Identifiers
PMID42312858
PMCPMC13343924
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390